{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:38:59Z","timestamp":1790419139889,"version":"4.1.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"suppl_I","license":[{"start":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T00:00:00Z","timestamp":1544486400000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,1]]},"DOI":"10.1093\/eurheartj\/suy039","type":"journal-article","created":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T04:04:06Z","timestamp":1544501046000},"page":"I2-I10","source":"Crossref","is-referenced-by-count":33,"title":["Use of levosimendan in acute heart failure"],"prefix":"10.1093","volume":"20","author":[{"given":"Veli-Pekka","family":"Harjola","sequence":"first","affiliation":[{"name":"Department of Cardiology, Helsinki University Hospital, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Giannakoulas","sequence":"additional","affiliation":[{"name":"Cardiology Department, AHEPA University Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"von Lewinski","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Medical University of Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Matskeplishvili","sequence":"additional","affiliation":[{"name":"Lomonosov Moscow State University Medical Centre, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia and Intensive Care, INSERM UMR 942, Lariboisi\u00e8re Hospital, University of Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Papp","sequence":"additional","affiliation":[{"name":"Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H G","family":"Schwinger","sequence":"additional","affiliation":[{"name":"Medizinische Klinik II, Klinikum Weiden, Akademisches Lehrkrankenhaus der Universit\u00e4t Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Pollesello","sequence":"additional","affiliation":[{"name":"Orion Pharma, Critical Care Proprietary Products, PO Box 65, FIN-02101 Espoo, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T","family":"Parissis","sequence":"additional","affiliation":[{"name":"Second Cardiology Department and Heart Failure Unit, Attikon Teaching Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,12,11]]},"reference":[{"key":"key\n\t\t\t\t2019010403583954100_suy039-B1","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ejhf.682","article-title":"Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry","volume":"19","author":"Arrigo","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ejhf.260","article-title":"Clinical picture and risk prediction of short-term mortality in cardiogenic shock","volume":"17","author":"Harjola","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B4","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1161\/01.CIR.98.20.2141","article-title":"Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium","volume":"98","author":"Hasenfuss","year":"1998","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00005344-200404000-00011","article-title":"Effects of levosimendan and milrinone on oxygen consumption in isolated guinea-pig heart","volume":"43","author":"Kaheinen","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/01.fjc.0000137163.22359.17","article-title":"Effect of levosimendan on balance between ATP production and consumption in isolated perfused guinea-pig heart before ischemia or after reperfusion","volume":"44","author":"Eriksson","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0014-2999(01)00997-9","article-title":"Improved survival with simendan after experimental myocardial infarction in rats","volume":"419","author":"Levijoki","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/1074248406289286","article-title":"Effect of levosimendan and milrinone on regional myocardial ischemia\/reperfusion-induced arrhythmias in dogs","volume":"11","author":"Papp","year":"2006","journal-title":"J Card Pharmacol Therapeut"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/0091270002042001005","article-title":"Pharmacodynamics and safety of a new calcium sensitizer, levosimendan, and its metabolites during an extended infusion in patients with severe heart failure","volume":"42","author":"Kivikko","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B10","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0735-1097(00)00961-X","article-title":"Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure","volume":"36","author":"Nieminen","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/01.CIR.0000043245.00859.11","article-title":"Sustained hemodynamic effects of intravenous levosimendan","volume":"107","author":"Kivikko","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jchf.2012.12.004","article-title":"Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure","volume":"1","author":"Packer","year":"2013","journal-title":"JACC Heart Fail"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.amjcard.2016.10.022","article-title":"Use of biomarkers to predict readmission for congestive heart failure","volume":"119","author":"Sudharshan","year":"2017","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B14","first-page":"101","article-title":"Five-year mortality in cardiac surgery patients with low cardiac output syndrome treated with levosimendan: prognostic evaluation of NT-proBNP and C-reactive protein","volume":"64","author":"Torrado","year":"2016","journal-title":"Minerva Cardioangiol"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B15","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00392-016-1009-6","article-title":"Similar hemodynamic decongestion with vasodilators and inotropes: systematic review, meta-analysis, and meta-regression of 35 studies on acute heart failure","volume":"105","author":"Ishihara","year":"2016","journal-title":"Clin Res Cardiol"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(02)09455-2","article-title":"Efficacy and safety of intravenous levosimendan, a novel calcium sensitiser, in severe low output heart failure: results of a randomised, double-blind comparison with dobutamine (LIDO Study)","volume":"360","author":"Follath","year":"2002","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B17","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1053\/euhj.2001.3158","article-title":"Safety and efficacy of a novel calcium sensitiser, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction: a randomized, placebo-controlled, double-blind study (RUSSLAN)","volume":"23","author":"Moiseyev","year":"2002","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B18","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs dobutamine for patients with acute decompensated heart failure. The SURVIVE Randomized Trial","volume":"297","author":"Mebazaa","year":"2007","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00134-010-2073-4","article-title":"Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods","volume":"37","author":"Mebazaa","year":"2011","journal-title":"Intensive Care Med"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B20","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ejhf.991","article-title":"Long-term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure Long-Term Registry","volume":"20","author":"Mebazaa","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B21","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/CCM.0b013e318232962a","article-title":"Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies","volume":"40","author":"Landoni","year":"2012","journal-title":"Crit Care Med"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B22","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/eurjhf\/hfn045","article-title":"Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE","volume":"11","author":"Mebazaa","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B23","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1053\/j.jvca.2015.03.023","article-title":"Levosimendan treatment for heart failure: a systematic review and meta-analysis","volume":"29","author":"Gong","year":"2015","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B24","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jchf.2014.10.007","article-title":"Incidence, temporal trends, and prognostic impact of heart failure complicating acute myocardial infarction. The SWEDEHEART Registry (Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended therapies): a study of 199, 851 patients admitted with index acute myocardial infarctions, 1996 to 2008","volume":"3","author":"Desta","year":"2015","journal-title":"JACC Heart Fail"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B25","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.jacc.2004.02.052","article-title":"The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia","volume":"43","author":"Sonntag","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B26","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ahj.2004.10.013","article-title":"Levosimendan improves hemodynamics and coronary flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction and left ventricular dysfunction","volume":"150","author":"De Luca","year":"2005","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.echo.2005.08.016","article-title":"Effects of levosimendan on left ventricular diastolic function after primary angioplasty for acute anterior myocardial infarction: a Doppler echocardiographic study","volume":"19","author":"De Luca","year":"2006","journal-title":"J Am Soc Echocardiogr"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/eurjhf\/hfs215","article-title":"Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study","volume":"15","author":"Husebye","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000360933","article-title":"Enhancement of myocardial function and reduction of injury with levosimendan after percutaneous coronary intervention for acute myocardial infarction: a pilot study","volume":"128","author":"Wu","year":"2014","journal-title":"Cardiology"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000357864","article-title":"Efficacy of intravenous levosimendan in patients with heart failure complicated by acute myocardial infarction","volume":"128","author":"Jia","year":"2014","journal-title":"Cardiology"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B31","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/eurjhf\/hfq032","article-title":"Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers","volume":"12","author":"Bergh","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B32","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1111\/1755-5922.12047","article-title":"Safety and feasibility of levosimendan administration in takotsubo cardiomyopathy: a case series","volume":"31","author":"Santoro","year":"2013","journal-title":"Cardiovasc Ther"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B33","doi-asserted-by":"crossref","first-page":"610","DOI":"10.5603\/CJ.a2016.0100","article-title":"Levosimendan accelerates recovery in patients with takotsubo cardiomyopathy","volume":"23","author":"Yaman","year":"2016","journal-title":"Cardiol J"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijcard.2016.05.009","article-title":"The role of levosimendan in acute heart failure complicating acute coronary syndrome: a review and expert consensus opinion","volume":"218","author":"Nieminen","year":"2016","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B35","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10557-013-6485-6","article-title":"Renal effects of levosimendan: a consensus report","volume":"27","author":"Yilmaz","year":"2013","journal-title":"Cardiovasc Drugs Ther"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ejhf.9","article-title":"Levosimendan improves renal function in acute decompensated heart failure: possible underlying mechanisms","volume":"16","author":"Fedele","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B37","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2459\/JCM.0000000000000244","article-title":"Effects of levosimendan on markers of kidney function in patients with acutely decompensated heart failure and renal impairment","volume":"18","author":"Rafouli-Stergiou","year":"2017","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B38","doi-asserted-by":"crossref","first-page":"e008455","DOI":"10.1161\/JAHA.117.008455","article-title":"Differential effects of levosimendan and dobutamine on glomerular filtration rate in patients with heart failure and renal impairment: a randomized double-blind controlled trial","volume":"7","author":"Lannemyr","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B39","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1124\/jpet.112.193961","article-title":"Levosimendan protection against kidney ischemia\/reperfusion injuries in anesthetized pigs","volume":"342","author":"Grossini","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B40","doi-asserted-by":"crossref","DOI":"10.1053\/j.jvca.2018.02.039","article-title":"Effect of levosimendan on renal outcome in cardiac surgery patients with chronic kidney disease and perioperative cardiovascular dysfunction: a substudy of a multicenter randomized trial","author":"Zangrillo","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B41","first-page":"35","article-title":"Beneficial impact of levosimendan in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials","volume":"7","author":"Bove","year":"2015","journal-title":"Heart Lung Vessel"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B42","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1053\/j.ajkd.2015.09.015","article-title":"Levosimendan for prevention of acute kidney injury after cardiac surgery: a meta-analysis of randomized controlled trials","volume":"67","author":"Zhou","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B43","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/crj.12699","article-title":"Efficacy and safety of a calcium sensitizer, levosimendan, in patients with right heart failure due to pulmonary hypertension","volume":"12","author":"Jiang","year":"2018","journal-title":"Clin Respir J"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/0091270008325150","article-title":"Repetitive dosing of intravenous levosimendan improves pulmonary hemodynamics in patients with pulmonary hypertension: results of a pilot study","volume":"49","author":"Kleber","year":"2009","journal-title":"J Clin Pharmacol"},{"key":"key\n\t\t\t\t2019010403583954100_suy039-B45","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ijcard.2015.10.240","article-title":"Calcium sensitizers: what have we learned over the last 25 years?","volume":"203","author":"Pollesello","year":"2016","journal-title":"Int J Cardiol"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/20\/suppl_I\/I2\/27378039\/suy039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:47:06Z","timestamp":1573087626000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article\/20\/suppl_I\/I2\/5237461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":45,"journal-issue":{"issue":"suppl_I","published-online":{"date-parts":[[2018,12,11]]},"published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/suy039","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12]]},"published":{"date-parts":[[2018,12,1]]}}}